[Current aspects of immunosuppressive therapy of collagen diseases].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001215:Asparaginase / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003095:Collagen Diseases / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003882:Dermatomyositis / Q000188:drug therapy; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D001215:Asparaginase
Attuali aspetti della terapia immunodepressiva delle connettiviti.